The Effect of OSA on Severity and Prognosis of Patients With IgAN

Not yet recruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

July 15, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

June 30, 2026

Conditions
Obstructive Sleep ApneaIgA Nephropathy
Interventions
DEVICE

Continuous Positive Airway Pressure

The intervention in this study involves the use of Continuous Positive Airway Pressure (CPAP) treatment. Although the study is designed as an observational cohort study, where patients self-selected whether to receive treatment rather than being assigned, there is still an intervention project, CPAP, present in the observational cohort. CPAP is a commonly used therapy for obstructive sleep apnea (OSA) and other sleep-related breathing disorders. The principle of CPAP treatment lies in maintaining a constant airway pressure during sleep to prevent the collapse of the upper airway and ensure unobstructed breathing. The patient wears a mask connected to a CPAP machine, which generates a steady stream of air to provide the necessary pressure.

All Listed Sponsors
lead

Peking University First Hospital

OTHER

NCT06393036 - The Effect of OSA on Severity and Prognosis of Patients With IgAN | Biotech Hunter | Biotech Hunter